Wednesday, March 2, 2016
6:30 am - 7:00 pm
7:00 am - 8:15 am
8:30 am - 9:25 am
Civilization's greatest accomplishment may be the doubling of worldwide average life expectancy during the 20th century. After 4 million years of evolution that yielded an increase of only 11 years, in less than a century human life spans were extended by 40 years. That's a major reason real economic output is eight times greater than in the 19th century. Medical research and public health were the primary drivers of that accomplishment--through sanitation, vaccines, reduced infant mortality, food and water security, auto and workplace safety, better nutrition and tobacco reduction, to name a few advances. Will the next century bring a world where cancer, heart disease, hypertension, obesity, malaria, dementia and many other health scourges have been eliminated or controlled? How can we get there, and if we do, can we spread the benefits more equally worldwide? Who is leading the charge? This open-ended discussion will address what changes we can -- and should -- expect in the near and distant future, and what those advances mean for our health and prosperity.
Welcoming Remarks
Mike Klowden, CEO, Milken Institute
Moderator
Richard Besser, Chief Health and Medical Editor, ABC News
Speakers
Nancy Brown, CEO, American Heart Association
Thomas Farley, Commissioner of Health, Philadelphia
Joseph Jimenez, CEO, Novartis
Fred Upton, U.S. Congressman, Michigan; Chairman, Energy and Commerce Committee, House of Representatives
9:30 am - 9:50 am
Milken Institute Chairman Mike Milken welcomed more than 500 public health advocates -- deans of schools of public health, government officials, philanthropists, corporate executives, physicians and scientists -- to the first-ever Milken Institute Public Health Summit by focusing on a half-century of progress in medical research and urging participants to increase collaboration that will result in similar gains in public health through increased length and higher-quality of life and by creating opportunities to drive economic growth.
Welcoming Remarks
Michael Milken, Chairman, Milken Institute
9:55 am - 10:10 am
Atul Butte -- a renowned physician and researcher in bioinformatics, precision medicine and big data -- discussed remarkable new tools that are accelerating progress in public health. These include the ability to create and mine massive databases that pinpoint risks to highly specific population subsets, and help improve care for millions of patients.
Presenter
Atul Butte, Director, Institute of Computational Health Sciences, and Professor of Pediatrics, University of California, San Francisco
10:20 am - 11:10 am
10:20 am - 11:10 am
Inadequate health care is a harsh reality for both the inner-city poor and isolated rural populations. In both cases, lives are shortened or made difficult by unaddressed health problems, including mental illness, substance abuse, heart disease and environmental contamination. Inner-city and rural Americans also share the problem of access to care. Even though 20 percent of Americans live in rural areas, fewer than 10 percent of physicians choose to work in their communities. Large metropolitan areas have some of the best health-care facilities and attract large numbers of medical professionals, but, again, few practice in poor neighborhoods. Overcrowded, badly maintained housing contributes to inner-city health problems by exposing people to dangerous contaminants and creating an environment of stress and violence. Our panelists will discuss these and other disparities in health care and offer practical solutions to address the problems.
Moderator
Dan Diamond, Author, Politico Pulse
Speakers
Jehan El-Bayoumi, Founding Director, Rodham Institute, School of Medicine and Health Sciences, George Washington University
Jewel Mullen, Principal Deputy Assistant Secretary for Health, U.S. Department of Health and Human Services
LaQuandra Nesbitt, Director, Department of Health, Washington, D.C.
Raul Pino, Acting Commissioner, Connecticut Department of Public Health
10:20 am - 11:10 am
Only a few decades ago, before the discovery of antibiotics, a small cut could turn into a life-threatening infection. Now, it is difficult to imagine a world without these "miracle" drugs. But bacteria are evolving to outsmart even the most powerful antibiotics. If you are infected with a drug-resistant strain -- whether you're in a rural area of a developing nation or a world-class hospital -- there is little that doctors can do. Researchers estimate that antimicrobial resistance could kill 300 million people in the next 35 years unless a solution is found. The threat is economic as well. Unchecked, superbugs may stunt global economic output by $50 trillion to $100 trillion over the next 35 years. Can stakeholders from the public and private sectors work together to find concrete solutions? Has the heavy use of antibiotics in farm animals accelerated the growth of drug-resistant bacteria? Our expert panel offers practical advice and insights on the scientific advances aimed at defeating superbugs.
Moderator
Maryn McKenna, Journalist and Author; Specialist in Public Health, Global Health and Food Policy
Speakers
Beth Bell, Director, National Center for Emerging and Zoonotic Infectious Diseases, CDC
Barry Eisenstein, Distinguished Physician, Antimicrobials, Merck & Co., Inc.
Lance Price, Director, Antibiotic Resistance Action Center, and Professor, Milken Institute School of Public Health, George Washington University
Zachary Rubin, Medical Director, Clinical Epidemiology and Infection Prevention, University of California, Los Angeles
10:20 am - 11:10 am
The growing burden of chronic disease is a costly threat to patients, their families and the economy. One in two adult Americans lives with at least one chronic condition such as diabetes, cardiovascular disease or dementia. Further, one in three live with two or more. The medical costs are staggering, but the drag on long-term economic growth and productivity losses associated with absenteeism and "presenteeism" for patients and informal caregivers are many times greater. Many chronic diseases are preventable. How much could we save in treatment costs and economic loss by modifying unhealthy behaviors such as smoking, excessive alcohol consumption and drug abuse? How about the obesity epidemic? How much could we save by simply eating better and exercising more? Can the movement toward a value-based care delivery system--in which payers pay providers based not on procedures--but on health and cost-related outcomes, make a difference?
Moderator
Ross DeVol, Chief Research Officer, Milken Institute
Speakers
Nancy Brown, CEO, American Heart Association
Neal Kaufman, Chief Medical Officer, Canary Health; Adjunct Professor of Medicine and Public Health, University of California, Los Angeles
Kristen Miranda, Senior Vice President, Strategic Partnerships and Innovation, Blue Shield of California
Hugh Waters, Health Economist and Associate Professor, University of North Carolina Schools of Nursing and Public Health
Otis Webb Brawley, Chief Medical and Scientific Officer, Executive Vice President, American Cancer Society
11:20 am - 12:10 pm
The last century has seen advances in longevity that would have been unimaginable to prior generations. Longer life span is a remarkable accomplishment, but more must be done to extend health span -- the length of time we enjoy optimal health. From the battle to control chronic disease to the efforts to conquer Alzheimer's, there's much work to do. The stakes could not be higher for individuals, families and countries with aging populations. But hope is on the horizon. Advances in genomics and personalized medicine enable customized care. Awareness about the benefits of nutrition, exercise and purposeful activity is growing. Digital health tools empower individuals, and priorities for reimbursing insurance premiums to health-conscious employees are changing. What can leaders in health, business, philanthropy, policy and other domains do to accelerate change? Our panel of experts will shed light on the landscape and prospects for a future of healthy aging.
Moderator
Paul Irving, Chairman, Center for the Future of Aging, Milken Institute
Speakers
Pinchas Cohen, Dean, Leonard Davis School of Gerontology, University of Southern California
Linda Fried, Dean and DeLamar Professor of Public Health, Mailman School of Public Health, Columbia University; Senior Vice President, Columbia University Medical Center
Freda Lewis-Hall, Executive Vice President and Chief Medical Officer, Pfizer Inc.
Robin Mockenhaupt, Chief of Staff, Robert Wood Johnson Foundation
11:20 am - 12:10 pm
We constantly hear that technology is improving medicine and medical research through genomics, better medical devices and the advent of precision medicine. We rarely hear about the ways technology is transforming public health. This session will focus on the less-discussed technological revolution taking place in public health and how big data can be mined, analyzed and curated to predict epidemics, improve quality of life and avoid preventable deaths. For example, correlation of health information and demographic data would enable doctors to analyze whether the physical environment contributes to a patient's illness. Does an asthma patient live near a heavily used freeway? Additionally, our panel will explore the potential of ever-growing databases collected from wearable devices and mobile apps that allow problems to be spotted before they occur. Additionally, our panel will explore the potential of ever-growing databases collected from wearable devices and mobile apps that allow problems to be spotted before they occur.
Moderator
Anna Barker, Fellow, FasterCures, a Center of the Milken Institute; Professor and Director, Transformative Healthcare Networks, and Co-Director, Complex Adaptive Systems Network, Arizona State University
Speakers
Helen Burstin, Chief Scientific Officer, National Quality Forum
Atul Butte, Director, Institute of Computational Health Sciences, and Professor of Pediatrics, University of California, San Francisco
Eric Friedman, Chief Technology Officer and Co-Founder, Fitbit
Kyu Rhee, Chief Health Officer, IBM Corp.
11:20 am - 12:10 pm
A third of U.S. adults and one in five children are obese. Not overweight, obese. Compare this with less than 15 percent in 1991. Obesity has become one of the nation's biggest causes of preventable chronic disease. The Milken Institute estimates that if the country could return to those levels from just two decades ago, we'd avoid as much as $1 trillion of direct and indirect costs each year. Philanthropists, companies, universities and government agencies have sought to reverse the steady growth of our waistlines, but the results so far are not encouraging. While pediatric obesity appears to have stabilized, adults continue to get fatter. So how can we fix this? Theories abound. Some say the problem stems from a lack of access to healthy choices and increasingly sedentary lifestyles. Others argue that unclear nutritional advice is the culprit. Still others point to cultural obstacles. This panel will explore what's working, what's not, and where we should focus our efforts.
Moderator
Cristina Alesci, Correspondent, CNN and CNNMoney
Speakers
Patrick Carroll, Group Vice President and Chief Medical Officer, Healthcare Clinic, Walgreen Co.
William Dietz, Director of the Sumner M. Redstone Global Center for Prevention and Wellness, Milken Institute School of Public Health, George Washington University
Debra Eschmeyer, Executive Director, Let's Move! and Senior Policy Advisor for Nutrition, The White House
Jonathan Fielding, Professor of Health Policy and Management, and Pediatrics, Schools of Public Health and Medicine, University of California, Los Angeles
David Heber, Professor Emeritus of Medicine and Public Health and Founding Director, Center for Human Nutrition, University of California, Los Angeles
12:30 pm - 1:50 pm
After testifying about the Zika virus emergency on Capitol Hill that morning, Dr. Frieden provided participants at the Public Health Summit with an update on this pressing public health threat.
Welcoming Remarks
Mike Klowden, CEO, Milken Institute
Moderator
Michael Gerson, Senior Advisor, ONE Campaign; Opinion Writer, the Washington Post
Speaker
Tom Frieden, Director, U.S. Centers for Disease Control and Prevention
2:00 pm - 2:50 pm
Don't drink that, don't eat those, pay this sin tax, lose weight, and don't even think about vaping around here! When public health policies run head-on into Americans' sense of freedom, the results are often very public disagreements about the role of government in encouraging -- or sometimes mandating -- healthy behaviors. Where should we draw the lines? Infectious disease is a matter of public safety, and most people agree that government action is appropriate. But what about obesity or salt consumption, both of which, it can be argued, affect the individual only? When an issue is determined to be within the purview of public health, what tools are available to encourage healthy choices without infringing on personal freedom? What responsibilities do private companies bear for the health of their customers and employees? How do we mitigate the risk that well-meaning policies may create harmful unintended consequences? Experts on different sides of the issue will explore the tradeoffs between advancing the public good and preserving personal choice.
Moderator
Megan McArdle, Columnist, Bloomberg View
Speakers
David Boaz, Executive Vice President, Cato Institute
Bob Casey, U.S. Senator, Pennsylvania; Ranking Member, Subcommittee on Nutrition, Agriculture Committee
LaQuandra Nesbitt, Director, Department of Health, Washington, D.C.
Doug Teitelbaum, Managing Principal, Homewood Capital, LLC
2:00 pm - 2:50 pm
We rarely say someone died from high blood pressure. The direct cause is often heart disease, a stroke or kidney failure. People who get new glasses, take a drug for erectile dysfunction, or complain of memory loss don't usually connect the dots to hypertension. Yet these and other conditions are often a consequence of the elevated blood pressure that affects one in three American adults and an estimated 1 billion people worldwide. The NIH says that suboptimal blood pressure accounts for $1 trillion globally in direct costs over 10 years while indirect costs approach $4 trillion annually. The economic and health burden is especially heavy in developing countries. In fact, hypertension is the only thing that kills more people than cigarettes -- its toll equals all infectious diseases combined. Yet effective treatments that are inexpensive, painless and safe are widely available. Basic screening can be conducted by public health workers, volunteers, pharmacists and nurses, in addition to primary care physicians and patients themselves. This panel of experts will explore why, worldwide, only 13 percent of those with hypertension have their blood pressure controlled and what can be done about it.
Moderator
Lynn Goldman, Michael and Lori Milken Dean, Milken Institute School of Public Health, George Washington University
Speakers
Kenneth Connell, Deputy Dean, Faculty of Medical Sciences, University of the West Indies
Nieca Goldberg, Medical Director, Joan H. Tisch Center for Women's Health, NYU Langone Medical Center
Stephen Kopecky, Professor of Medicine, Division of Cardiovascular Diseases, Mayo Clinic; Former President, American Society for Preventive Cardiology
Paul Whelton, Show Chwan Professor of Global Public Health, School of Public Health and Tropical Medicine, Tulane University
2:00 pm - 2:50 pm
There is an inextricable link between the health of a country and its economic development. From food security to infectious disease and maternal health, major global challenges threaten to stunt the recent GDP growth seen in many emerging and frontier countries. And with more and more investors looking to these markets to provide financial rewards, the risks associated with inaction are daunting. The United Nations' Sustainable Development Goals, which address education, food security, global health, water and the environment, provide a framework for the public and private sectors to collaborate to lift people out of poverty and promote overall wellbeing. But with aggressive targets, what are the best practices to meet the SGDs? How will these massive programs be financed? Innovative solutions are needed. Our panelists will discuss the challenges and opportunities they see as they change the world.
Moderator
Matthew Bishop, Senior Editor, Economist Group
Speakers
David Barash, Chief Medical Officer and Executive Director, Global Health Portfolio, GE Foundation
Stefano Bertozzi, Dean, School of Public Health, and Professor, Health Policy and Management, University of California, Berkeley
Deborah Birx, Ambassador-at-Large, U.S. Global AIDS Coordinator and Special Representative for Global Health Diplomacy, State Department
Jacqueline Shea, CEO, Aeras
3:00 pm - 3:50 pm
Tuberculosis. Hepatitis. HIV/AIDS. Malaria. Polio. Ebola. Zika. We see news about these diseases on a regular basis, and the reports don't always come from a far, far away place. These deadly illnesses often strike very close to home. Worldwide, infectious diseases are one of the leading causes of death in adults, and the statistics are worse for children. Medical advances have helped curtail their spread, but they persist because of poor sanitation, lack of education, inadequate infrastructure and poverty. As we saw with the Ebola outbreak in 2014, an infectious disease can turn into a devastating epidemic very quickly, putting the scientific community in a race against time to treat the victims. This session will feature leaders from the front lines of the fight against well-known diseases and the yet-to-be named next outbreak.
Moderator
Michael Gerson, Senior Advisor, ONE Campaign; Opinion Writer, the Washington Post
Speakers
Michael Kurilla, Director, Office of Biodefense Research Resources and Translational Research, and Associate Director, Biodefense Product Development, National Institute of Allergy and Infectious Diseases
Vanina Laurent-Ledru, Associate Vice President, Vaccination Policy and Advocacy, Sanofi Pasteur
Pranav Shetty, Global Emergency Health Coordinator, International Medical Corps
Moncef Slaoui, Chairman, Vaccines, GSK
3:00 pm - 3:50 pm
3:00 pm - 3:50 pm
For too long, mental illness -- a leading cause of lost economic output -- has been pushed aside in lieu of other public health priorities. However, with the cost of mental disorders poised to surpass that of all other noncommunicable diseases, many foundations and policymakers across the globe have begun devoting more resources and attention to the issue. The United Nations and the World Health Organization have agreed to make prevention and treatment a priority. What is new research telling us about the causes and progression of mental illnesses, and what are the implications for patients and caregivers? What best practices and evidence-based models can we highlight, and what is needed to apply these approaches on a larger scale, particularly in places with limited health-care infrastructure?
Moderator
Margaret Anderson, Executive Director, FasterCures, a Center of the Milken Institute
Speakers
Olga Acosta Price, Associate Professor of Prevention and Community Health, Milken Institute School of Public Health, George Washington University
Pamela Collins, Director, Office for Research on Disparities and Global Mental Health, National Institute of Mental Health
Paolo del Vecchio, Director, Center for Mental Health Services, Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services
Charles Ingoglia, Senior Vice President, Public Policy and Practice Improvement, National Council for Behavioral Health
3:00 pm - 3:50 pm
U.S. companies spend billions each year on direct health expenses and even more on the indirect costs of an unhealthy workforce -- absenteeism, reduced productivity and disability. As much as three-quarters of those costs stem from chronic diseases, many of which can be avoided or mitigated through lifestyle changes. It's no wonder, then, that forward-looking companies are creating innovative prevention and wellness programs and community initiatives to encourage better health choices. Congress and the administration -- through programs such as the Prevention and Public Health Fund -- are promoting workplace initiatives as part of a broader effort to strengthen public health. This panel will explore how businesses are making small investments today to avoid large expenditures tomorrow.
Moderator
Ryan Shadrick Wilson, Chief Strategy Officer and General Counsel, Partnership for a Healthier America
Speakers
John Agwunobi, Chief Health and Nutrition Officer, Herbalife
Steve Burd, Founder and CEO, Burd Health; Former Chairman and CEO, Safeway Inc.
Jeffrey Levi, Professor of Health Policy, Milken Institute School of Public Health, George Washington University
Mark Wagar, President, Heritage Medical Systems
4:00 pm - 4:15 pm
Barbara Bush, CEO and co-founder of Global Health Corps, shared insights on preparing the next generation of health leaders to make health equity a reality across the globe. Bush outlined the mission and framework of Global Health Corps, which organizes fellowships for young professionals to work in poor communities in Africa and the U.S. She also discussed the crucial need for leaders to develop skills such as storytelling and mentorship, as well as traits like empathy and resilience, alongside business acumen and systems thinking.
Presenter
Barbara Bush, CEO and Co-Founder, Global Health Corps
4:20 pm - 5:20 pm
The fight against cancer is moving forward faster than ever thanks to advances in public health and medical research, including more focused prevention strategies, powerful diagnostic tools, vaccines, stem cell treatments, precision therapies and immunology drugs. But for the millions who will be diagnosed this year, and for their families, faster is not fast enough. We can do better. With this in mind, the White House recently announced the National Cancer Moonshot, a $1 billion initiative to eliminate cancer as we know it. The Moonshot represents a bold new opportunity to accelerate our understanding of, and our ability to prevent and treat, all cancers. To be successful, this initiative will require unprecedented partnerships between the public health and medical research communities, and among government agencies, industry, philanthropy, academia, patients and foundations. We'll hear from a diverse panel of leading decision-makers in these fields on how they are committed to relegating cancer to the history books.
Moderator
Michael Milken, Chairman, Milken Institute
Speakers
Francis Collins, Director, National Institutes of Health
Linda Fried, Dean and DeLamar Professor of Public Health, Mailman School of Public Health, Columbia University; Senior Vice President, Columbia University Medical Center
Robert Hugin, Executive Chairman, Celgene
Freda Lewis-Hall, Executive Vice President and Chief Medical Officer, Pfizer Inc.
5:30 pm - 6:30 pm
6:30 pm - 9:00 pm
The first-ever Milken Institute Public Health Summit in Washington concluded with an inspired evening for the more than 500 participants that included deans of schools of public health, government officials, philanthropists, corporate executives, physicians and scientists. Among the highlights, NIH Director Francis Collins, FDA Commisioner Robert Califf and CDC Director Tom Frieden each made remarks and joined on stage together. House of Representatives Democratic Leader Nancy Pelosi and Congressman Fred Upton, chairman of the Energy and Commerce Committee, also joined Milken Institute Chairman Mike Milken in calling for greater collaboration to improve public health worldwide.